STOCKWATCH
·
Hospital
Quarterly Result9 Feb 2026, 09:33 pm

Asarfi Hospital Reports 40% YoY Revenue Growth in Q3FY26, Driven by Higher Patient Volumes and Improved Case Mix

AI Summary

Asarfi Hospital Ltd, a leading Dhanbad-based healthcare provider, has reported a 40% YoY increase in revenue for the quarter ended December 31, 2025. The growth was primarily driven by higher patient volumes, improved average revenue per occupied bed (ARPOB), and a better case mix. The super-specialty unit saw a 42% YoY increase in IPD revenue and a 37% YoY growth in OPD revenue, while the cancer unit reported growth in high-acuity segments such as Cardiology, Neurosciences, Head & Neck, and Haemato Oncology. The company's EBITDA margin stood at 22% and PAT margin at 12% for the quarter.

Key Highlights

  • 40% YoY increase in Q3FY26 revenue
  • Higher patient volumes and improved ARPOB
  • Super-specialty unit reports 42% YoY growth in IPD revenue and 37% in OPD revenue
  • Cancer unit sees growth in high-acuity segments
  • EBITDA margin at 22% and PAT margin at 12%
ASARFI
Hospital
Asarfi Hospital Ltd

Price Impact